Bure Equity AB

  • Market Cap: Small Cap
  • Industry: Finance
  • ISIN: SE0000195810
SEK
247.80
1 (0.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Weak Long Term Fundamental Strength with a 6.27% CAGR growth in Operating Profits

 
2

The company has declared negative results in Dec 24 after 4 consecutive negative quarters

3

Risky -

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Finance

stock-summary
Market cap

SEK 18,641 Million (Small Cap)

stock-summary
P/E

3.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.09%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

28.13%

stock-summary
Price to Book

0.91

Revenue and Profits:
Net Sales:
193 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1,250 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.96%
0%
-8.96%
6 Months
-15.08%
0%
-15.08%
1 Year
-32.85%
0%
-32.85%
2 Years
-1.74%
0%
-1.74%
3 Years
1.23%
0%
1.23%
4 Years
-38.2%
0%
-38.2%
5 Years
-7.47%
0%
-7.47%

Bure Equity AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-27.50%
EBIT Growth (5y)
6.27%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
3.55%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.72%
ROE (avg)
18.65%
Valuation key factors
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
0.97
EV to EBIT
3.38
EV to EBITDA
3.38
EV to Capital Employed
0.97
EV to Sales
91.91
PEG Ratio
0.17
Dividend Yield
1.02%
ROCE (Latest)
28.62%
ROE (Latest)
27.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 257.41% vs 575.00% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 52.49% vs -103.80% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "193.00",
          "val2": "54.00",
          "chgp": "257.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1,250.00",
          "val2": "-2,636.00",
          "chgp": "52.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,250.00",
          "val2": "-2,631.00",
          "chgp": "52.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6,481.90%",
          "val2": "-48,833.30%",
          "chgp": "4,235.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.94% vs -7.21% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.76% vs 151.42% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "210.00",
          "val2": "206.00",
          "chgp": "1.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,707.00",
          "val2": "4,734.00",
          "chgp": "20.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,735.00",
          "val2": "4,749.00",
          "chgp": "20.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27,152.40%",
          "val2": "22,956.30%",
          "chgp": "419.61%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
193.00
54.00
257.41%
Operating Profit (PBDIT) excl Other Income
-1,250.00
-2,636.00
52.58%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1,250.00
-2,631.00
52.49%
Operating Profit Margin (Excl OI)
-6,481.90%
-48,833.30%
4,235.14%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 257.41% vs 575.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 52.49% vs -103.80% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
210.00
206.00
1.94%
Operating Profit (PBDIT) excl Other Income
5,707.00
4,734.00
20.55%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
5,735.00
4,749.00
20.76%
Operating Profit Margin (Excl OI)
27,152.40%
22,956.30%
419.61%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 1.94% vs -7.21% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 20.76% vs 151.42% in Dec 2023

stock-summaryCompany CV
About Bure Equity AB stock-summary
stock-summary
Bure Equity AB
Finance
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Company Coordinates stock-summary
Company Details
Nybrogatan 6 , STOCKHOLM None : 114 34
stock-summary
Tel: 46 8 614002046 8 6140020
stock-summary
Registrar Details